These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 12476080)

  • 1. Interleukin-13 in asthma.
    Wills-Karp M; Chiaramonte M
    Curr Opin Pulm Med; 2003 Jan; 9(1):21-7. PubMed ID: 12476080
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interleukin-13 in asthma pathogenesis.
    Wills-Karp M
    Curr Allergy Asthma Rep; 2004 Mar; 4(2):123-31. PubMed ID: 14769261
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interleukin-13 in asthma pathogenesis.
    Wills-Karp M
    Immunol Rev; 2004 Dec; 202():175-90. PubMed ID: 15546393
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intrinsic defect in T cell production of interleukin (IL)-13 in the absence of both IL-5 and eotaxin precludes the development of eosinophilia and airways hyperreactivity in experimental asthma.
    Mattes J; Yang M; Mahalingam S; Kuehr J; Webb DC; Simson L; Hogan SP; Koskinen A; McKenzie AN; Dent LA; Rothenberg ME; Matthaei KI; Young IG; Foster PS
    J Exp Med; 2002 Jun; 195(11):1433-44. PubMed ID: 12045241
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CpG oligodeoxynucleotides can reverse Th2-associated allergic airway responses and alter the B7.1/B7.2 expression in a murine model of asthma.
    Serebrisky D; Teper AA; Huang CK; Lee SY; Zhang TF; Schofield BH; Kattan M; Sampson HA; Li XM
    J Immunol; 2000 Nov; 165(10):5906-12. PubMed ID: 11067952
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interleukin-13: central mediator of allergic asthma.
    Wills-Karp M; Luyimbazi J; Xu X; Schofield B; Neben TY; Karp CL; Donaldson DD
    Science; 1998 Dec; 282(5397):2258-61. PubMed ID: 9856949
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exacerbation of experimental allergic asthma by augmented Th2 responses in WSX-1-deficient mice.
    Miyazaki Y; Inoue H; Matsumura M; Matsumoto K; Nakano T; Tsuda M; Hamano S; Yoshimura A; Yoshida H
    J Immunol; 2005 Aug; 175(4):2401-7. PubMed ID: 16081811
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IL-5-induced airway eosinophilia--the key to asthma?
    Hamelmann E; Gelfand EW
    Immunol Rev; 2001 Feb; 179():182-91. PubMed ID: 11292022
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Th2 lymphocyte products IL-4 and IL-13 rapidly induce airway hyperresponsiveness through direct effects on resident airway cells.
    Venkayya R; Lam M; Willkom M; Grünig G; Corry DB; Erle DJ
    Am J Respir Cell Mol Biol; 2002 Feb; 26(2):202-8. PubMed ID: 11804871
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Imperatorin exerts antiallergic effects in Th2-mediated allergic asthma via induction of IL-10-producing regulatory T cells by modulating the function of dendritic cells.
    Lin CL; Hsiao G; Wang CC; Lee YL
    Pharmacol Res; 2016 Aug; 110():111-121. PubMed ID: 27185659
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cooperative effects of Th2 cytokines and allergen on normal and asthmatic bronchial epithelial cells.
    Lordan JL; Bucchieri F; Richter A; Konstantinidis A; Holloway JW; Thornber M; Puddicombe SM; Buchanan D; Wilson SJ; Djukanović R; Holgate ST; Davies DE
    J Immunol; 2002 Jul; 169(1):407-14. PubMed ID: 12077271
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunopathogenesis of bronchial asthma.
    Buc M; Dzurilla M; Vrlik M; Bucova M
    Arch Immunol Ther Exp (Warsz); 2009; 57(5):331-44. PubMed ID: 19688187
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New insights into the role of cytokines in asthma.
    Renauld JC
    J Clin Pathol; 2001 Aug; 54(8):577-89. PubMed ID: 11477111
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chemokines in asthma: cooperative interaction between chemokines and IL-13.
    Zimmermann N; Hershey GK; Foster PS; Rothenberg ME
    J Allergy Clin Immunol; 2003 Feb; 111(2):227-42; quiz 243. PubMed ID: 12589338
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Involvement of interleukin-4, and -13 in the pathogenesis of allergic diseases].
    Izuhara K
    Rinsho Byori; 2001 Apr; 49(4):360-4. PubMed ID: 11391949
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutic effect of IL-13 immunoneutralization during chronic experimental fungal asthma.
    Blease K; Jakubzick C; Westwick J; Lukacs N; Kunkel SL; Hogaboam CM
    J Immunol; 2001 Apr; 166(8):5219-24. PubMed ID: 11290806
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Type 2 innate lymphoid cells: at the cross-roads in allergic asthma.
    van Rijt L; von Richthofen H; van Ree R
    Semin Immunopathol; 2016 Jul; 38(4):483-96. PubMed ID: 26965110
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selective blockade of NF-kappa B activity in airway immune cells inhibits the effector phase of experimental asthma.
    Desmet C; Gosset P; Pajak B; Cataldo D; Bentires-Alj M; Lekeux P; Bureau F
    J Immunol; 2004 Nov; 173(9):5766-75. PubMed ID: 15494529
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunologic basis of antigen-induced airway hyperresponsiveness.
    Wills-Karp M
    Annu Rev Immunol; 1999; 17():255-81. PubMed ID: 10358759
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro responsiveness to IL-18 in combination with IL-12 or IL-2 by PBMC from patients with bronchial asthma and atopic dermatitis.
    El-Mezayen RE; Matsumoto T
    Clin Immunol; 2004 Apr; 111(1):61-8. PubMed ID: 15093553
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.